FTSE All-Share
5.240,90
PKT
-24,84
PKT
-0,47
%
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 03.11.21 | BP Buy | UBS AG | |
| 03.11.21 | BP Hold | Deutsche Bank AG | |
| 03.11.21 | BP Overweight | JP Morgan Chase & Co. | |
| 03.11.21 | BP Conviction Buy List | Goldman Sachs Group Inc. | |
| 02.11.21 | AstraZeneca Buy | UBS AG | |
| 02.11.21 | BP Overweight | JP Morgan Chase & Co. | |
| 02.11.21 | BP Conviction Buy List | Goldman Sachs Group Inc. | |
| 02.11.21 | BP Sector Perform | RBC Capital Markets | |
| 02.11.21 | Rio Tinto Outperform | Credit Suisse Group | |
| 02.11.21 | BP Hold | Jefferies & Company Inc. | |
| 02.11.21 | Diageo Outperform | Credit Suisse Group | |
| 02.11.21 | HSBC Buy | Goldman Sachs Group Inc. | |
| 02.11.21 | Barclays Buy | Goldman Sachs Group Inc. | |
| 01.11.21 | HSBC Buy | UBS AG | |
| 01.11.21 | Unilever Market-Perform | Bernstein Research | |
| 01.11.21 | GSK Neutral | JP Morgan Chase & Co. | |
| 01.11.21 | BP Sector Perform | RBC Capital Markets | |
| 29.10.21 | Shell (ex Royal Dutch Shell) Buy | Deutsche Bank AG | |
| 29.10.21 | Shell (ex Royal Dutch Shell) Buy | Goldman Sachs Group Inc. | |
| 28.10.21 | GSK Hold | Deutsche Bank AG | |
| 28.10.21 | Shell (ex Royal Dutch Shell) Buy | UBS AG | |
| 28.10.21 | GSK Neutral | UBS AG | |
| 28.10.21 | GSK Hold | Kepler Cheuvreux | |
| 28.10.21 | GSK Underperform | Credit Suisse Group | |
| 28.10.21 | GSK Underweight | Barclays Capital | |
| 28.10.21 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 28.10.21 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 28.10.21 | Vodafone Group Overweight | JP Morgan Chase & Co. | |
| 27.10.21 | GSK Neutral | JP Morgan Chase & Co. | |
| 27.10.21 | GSK Buy | Goldman Sachs Group Inc. | |
| 27.10.21 | GSK Buy | Jefferies & Company Inc. | |
| 27.10.21 | HSBC Outperform | RBC Capital Markets | |
| 26.10.21 | HSBC Sell | Deutsche Bank AG | |
| 26.10.21 | AstraZeneca Buy | Deutsche Bank AG | |
| 26.10.21 | Rio Tinto Overweight | JP Morgan Chase & Co. | |
| 26.10.21 | HSBC Buy | Goldman Sachs Group Inc. | |
| 26.10.21 | HSBC Neutral | Credit Suisse Group | |
| 25.10.21 | HSBC Neutral | JP Morgan Chase & Co. | |
| 25.10.21 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 25.10.21 | HSBC Buy | UBS AG |